We are live on ! Find out more
VA

Vident Advisory Portfolio holdings

AUM $11.7B
1-Year Est. Return 37.32%
This Fund
S&P 500
This Quarter Est. Return
+13.81%
1 Year Est. Return
+37.32%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$10.5B
AUM Growth
+$1.56B
Cap. Flow
+$702M
Cap. Flow %
6.71%
Top 10 Hldgs %
20.79%
Holding
1,751
New
156
Increased
901
Reduced
550
Closed
119

Top Buys

Rank Stock Value
1
NOC icon
Northrop Grumman
NOC
+$31.6M
2
APP icon
Applovin
APP
+$29.6M
3
MSFT icon
Microsoft
MSFT
+$26M
4
FTNT icon
Fortinet
FTNT
+$24.6M
5
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$21.8M

Sector Composition

Rank Sector Weight
1 Technology 36.63%
2 Industrials 13.99%
3 Financials 11.83%
4 Consumer Discretionary 7.2%
5 Communication Services 7.05%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
UTHR icon
526
United Therapeutics
UTHR
$26.3B
$2.31M 0.02%
5,508
-9,071
-62% -$3.05M
IWM icon
527
iShares Russell 2000 ETF
IWM
$80.3B
$2.31M 0.02%
9,542
-285
-3% -$65.4K
HLN icon
528
Haleon
HLN
$43.8B
$2.31M 0.02%
257,327
-58,469
-19% -$563K
MNST icon
529
Monster Beverage
MNST
$93.2B
$2.3M 0.02%
34,221
+3,644
+12% +$227K
PFG icon
530
Principal Financial Group
PFG
$24B
$2.3M 0.02%
27,710
+512
+2% +$40.9K
HMY icon
531
Harmony Gold Mining
HMY
$9.92B
$2.3M 0.02%
126,560
+4,526
+4% +$68.4K
ROK icon
532
Rockwell Automation
ROK
$51.9B
$2.3M 0.02%
6,570
-7,792
-54% -$2.69M
NSC icon
533
Norfolk Southern
NSC
$77.1B
$2.29M 0.02%
7,619
+1,534
+25% +$426K
OMC icon
534
Omnicom Group
OMC
$23.5B
$2.29M 0.02%
28,034
+971
+4% +$73.3K
KMB icon
535
Kimberly-Clark
KMB
$37B
$2.29M 0.02%
18,379
+1,772
+11% +$229K
LNTH icon
536
Lantheus
LNTH
$7.03B
$2.28M 0.02%
44,533
-25,042
-36% -$1.56M
MAA icon
537
Mid-America Apartment Communities
MAA
$15.5B
$2.26M 0.02%
16,207
-4,567
-22% -$660K
NMR icon
538
Nomura Holdings
NMR
$28.6B
$2.26M 0.02%
310,297
+16,702
+6% +$117K
TFC icon
539
Truist Financial
TFC
$63.7B
$2.26M 0.02%
49,336
+4,536
+10% +$205K
TTWO icon
540
Take-Two Interactive
TTWO
$45.3B
$2.26M 0.02%
8,730
-347
-4% -$82.1K
TLK icon
541
Telkom Indonesia
TLK
$14.3B
$2.24M 0.02%
119,170
+15,618
+15% +$289K
GM icon
542
General Motors
GM
$78.7B
$2.23M 0.02%
36,514
+10,880
+42% +$607K
SKE
543
Skeena Resources
SKE
$3.37B
$2.21M 0.02%
120,068
+86,231
+255% +$1.41M
CBOE icon
544
Cboe Global Markets
CBOE
$30.2B
$2.21M 0.02%
9,004
-12,837
-59% -$3.08M
HPQ icon
545
HP
HPQ
$24.3B
$2.21M 0.02%
81,008
+11,429
+16% +$305K
STRA icon
546
Strategic Education
STRA
$1.78B
$2.2M 0.02%
+25,600
New +$2.06M
ATO icon
547
Atmos Energy
ATO
$29.7B
$2.2M 0.02%
12,887
-1,571
-11% -$254K
MCHP icon
548
Microchip Technology
MCHP
$42.3B
$2.2M 0.02%
34,203
+1,416
+4% +$96K
VTR icon
549
Ventas
VTR
$48.7B
$2.19M 0.02%
31,353
+616
+2% +$41.4K
CF icon
550
CF Industries
CF
$18.4B
$2.19M 0.02%
24,384
-882
-3% -$78.6K

Similar funds

Vident Advisory's Q3 2025 Portfolio in Review

As of Q3 2025, Vident Advisory held 1,751 positions worth $10.5B, up 18% from $8.91B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Vident Advisory deployed $702M of net new capital in Q3 2025, opening 156 new positions and adding to 901 existing holdings. Its largest new stake was IonQ: 256,676 shares worth $15.8M.

By sector, the portfolio is most concentrated in Technology at 37% of assets, down from 39% a quarter earlier, followed by Industrials and Financials.

On the sell side, the largest reduction was Palantir, an estimated $37.5M trimmed.

  • Vident Advisory's largest Q3 2025 buy was IonQ: 256,676 shares worth $15.8M.
  • Vident Advisory added most to Northrop Grumman in Q3 2025, an estimated $31.6M increase.
  • Vident Advisory's biggest Q3 2025 reduction was Palantir, cutting an estimated $37.5M.
  • Vident Advisory fully exited Rapid7 in Q3 2025, selling an estimated $4.8M.
  • Vident Advisory's ten largest holdings make up 21% of its $10.5B portfolio in Q3 2025.
  • Vident Advisory opened 156 new positions and closed 119 in Q3 2025.
  • Vident Advisory's portfolio value rose 18% quarter-over-quarter to $10.5B.

Based on Vident Advisory's 13F filing for Q3 2025, filed 14 Nov 2025.